Clinical Trial Update: Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ribociclib with everolimus in pediatric patients with recurrent or refractory malignant brain tumors; completed with posted results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Childhood Ependymoma
• Cns Embryonal Tumor Not Otherwise Specified
• Diffuse Intrinsic Pontine Glioma
• Malignant Glioma
• Medulloblastoma

Drugs mentioned

• Everolimus (everolimus)
• Ribociclib (ribociclib)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: CNS Embryonal Tumor, Not Otherwise Specified, Malignant Glioma | Phase 1 | Status: COMPLETED | Results posted: 2021-08-27